These success, together with a prior report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two support the idea of focusing on ACKR3 as a unique approach to modulate the opioid system, which could open up new therapeutic avenues for opioid-connected Diseases.We independently exploration, assessment,